Qube Research & Technologies LTD Dice Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$25.86 - $46.71 $2.96 Million - $5.34 Million
114,335 New
114,335 $5.31 Million
Q2 2022

Aug 15, 2022
BUY
$13.19 - $22.1 $236,140 - $395,656
17,903 New
17,903 $278,000
Q4 2021

Feb 01, 2022
SELL
$22.41 - $37.54 $152,119 - $254,821
-6,788 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$31.92 - $37.0 $216,672 - $251,156
6,788 New
6,788 $222,000

Others Institutions Holding DICE

# of Institutions
3
Shares Held
17.7K
Call Options Held
13K
Put Options Held
0
View Full List

About DICE Therapeutics, Inc.

DICE Quotes by TradingView
  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email